Search research articles
Contact Us
Filters
Showing results (171-180 of 204) with videos related to
Page
of 21
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2020
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
Anton Oseledchyk, Mary L Gemignani, Qin C Zhou, et al.
Gynecologic Oncology
|
October 17, 2016
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis
Amanda N Fader, James Java, Meaghan Tenney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Gynecologic Oncology
|
October 28, 2020
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function
Jeanne Carter, Helen Q Huang, Jane Armer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Gynecologic Oncology
|
November 5, 2019
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)
Jeanne Carter, Helen Q Huang, Jane Armer, et al.
Gynecologic Oncology
|
June 30, 2023
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications
Jacqueline Feinberg, Oliver Zivanovic, Michael Hannon, et al.
Gynecologic Oncology
|
March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues
Lea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.
Gynecologic Oncology
|
September 13, 2020
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study
Helmut Plett, Olga T Filippova, Annalisa Garbi, et al.
International Journal of Cancer
|
June 5, 2014
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
Oliver Zivanovic, Alina Abramian, Maximilian Kullmann, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 204) with videos related to
Sort By:
Page
of 21
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2020
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
Anton Oseledchyk, Mary L Gemignani, Qin C Zhou, et al.
Gynecologic Oncology
|
October 17, 2016
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis
Amanda N Fader, James Java, Meaghan Tenney, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Gynecologic Oncology
|
October 28, 2020
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function
Jeanne Carter, Helen Q Huang, Jane Armer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Gynecologic Oncology
|
November 5, 2019
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)
Jeanne Carter, Helen Q Huang, Jane Armer, et al.
Gynecologic Oncology
|
June 30, 2023
Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications
Jacqueline Feinberg, Oliver Zivanovic, Michael Hannon, et al.
Gynecologic Oncology
|
March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues
Lea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.
Gynecologic Oncology
|
September 13, 2020
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study
Helmut Plett, Olga T Filippova, Annalisa Garbi, et al.
International Journal of Cancer
|
June 5, 2014
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
Oliver Zivanovic, Alina Abramian, Maximilian Kullmann, et al.
Page
of 21